Patent Settlements: an Economic Point of View

This E-presentation is offering backgrounds information on the economic incentives underlying parties ‘decisions to choose between litigation and patent settlements in order to solve their disputes in the life pharmaceutical sector. After focussing on the different economic criteria taken into consideration by the parties and by the European Commission in their decision making process, the speaker counter argues the assessment made by the European Commission in these cases by concluding that patent settlements involving a value transfer can in some circumstances facilitate pro-competitive agreements.